Provided by Tiger Trade Technology Pte. Ltd.

Biogen

216.78
+2.431.13%
Post-market: 216.780.00000.00%19:30 EDT
Volume:722.35K
Turnover:156.95M
Market Cap:32.00B
PE:38.50
High:219.12
Open:217.76
Low:215.00
Close:214.35
52wk High:222.15
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.70
PE(LYR):24.66

Loading ...

Biogen price target raised to $200 from $185 at Barclays

TIPRANKS
·
Jul 29

Biogen beats estimates as new medicines overtake multiple sclerosis business

Robert Langreth / Bloomberg
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Barclays Adjusts Biogen Price Target to $200 From $185, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28

Biogen Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts Price Target on Biogen to $210 From $190, Maintains Neutral Rating

MT Newswires Live
·
Jul 24

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Earning Preview: Biogen Q2 revenue is expected to increase by 5.80%, majority of institutions hold constructive views

Earnings Agent
·
Jul 22

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 22

Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions

TIPRANKS
·
Jul 22

Biogen is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 21

U.S. Research Roundup-colgate-palmolive, IBM, Unitedhealth

Reuters
·
Jul 21

Biogen (BIIB) Expands Its Alzheimer’s Pipeline, Is The 9% Undervaluation Still There?

Simply Wall St.
·
Jul 21

Biogen Inc. Stock Falls 2.9%, Underperforms Peers

Dow Jones
·
Jul 21

Goldman Sachs Adjusts Price Target on Biogen to $271 From $250, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Biogen, Bloom, First Solar, Oklo, NNE Trending With Analysts

TIPRANKS
·
Jul 18

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Movement Alert|Biogen Rises 5.03% in Regular Trading, Canada Drug Agency Recommends Leqembi for Public Insurance Coverage

Market Focus
·
Jul 17